A pH-dependent stabilization of an active site loop observed from low and high pH crystal structures of mutant monomeric glycinamide ribonucleotide transformylase at 1.8 to 1.9 A.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Molecular Biology

• Publication date

  1998-08-21

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/JMBI.1998.1931PMID 9698564
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AG2034: a novel inhibitor of glycinamide ribonucleotide formyltransferase

  2004cited by this paper
• A single mutation disrupts the pH-dependent dimerization of glycinamide ribonucleotide transformylase.

  1998cited by this paper
• Contributions of protein structure-based drug design to cancer chemotherapy.

  1997cited by this paper
• Conformational substates in enzyme mechanism: The 120 K structure of α‐lytic protease at 1.5 Å resolution

  1997cited by this paper
• A direct comparison of helix propensity in proteins and peptides.

  1997cited by this paper
• Cryocrystallography of biological macromolecules

  1997cited by this paper
• Contributions of protein structure-based drug design to cancer chemotherapy.

  1997cited by this paper
• Use of 1H NMR spectroscopy and computer simulations To analyze histidine pKa changes in a protein tyrosine phosphatase: experimental and theoretical determination of electrostatic properties in a small protein.

  1997cited by this paper
• Roles of histidine 31 and tryptophan 34 in the structure, self-association, and folding of murine interleukin-6.

  1997cited by this paper
• Protein structure-based design, synthesis, and biological evaluation of 5-thia-2,6-diamino-4(3H)-oxopyrimidines: potent inhibitors of glycinamide ribonucleotide transformylase with potent cell growth inhibition.

  1997cited by this paper
• Checking your imagination: applications of the free R value.

  1996cited by this paper
• Glycinamide ribonucleotide transformylase undergoes pH-dependent dimerization.

  1996cited by this paper
• A rapid screen of active site mutants in glycinamide ribonucleotide transformylase.

  1996cited by this paper
• Towards structure-based drug design: crystal structure of a multisubstrate adduct complex of glycinamide ribonucleotide transformylase at 1.96 A resolution.

  1995cited by this paper
• Three new crystal structures of point mutation variants of monoTIM: conformational flexibility of loop-1, loop-4 and loop-8.

  1995cited by this paper
• Thermal expansion of hen egg-white lysozyme. Comparison of the 1.9 A resolution structures of the tetragonal form of the enzyme at 100 K and 298 K.

  1994cited by this paper
• Crystallographic studies of Savinase, a subtilisin-like proteinase, at pH 10.5.

  1994cited by this paper
• AMoRe: an automated package for molecular replacement

  1994cited by this paper
• The CCP4 suite: programs for protein crystallography.

  1994cited by this paper
• Inhibitors of thymidylate synthase and glycinamide ribonucleotide transformylase.

  1994cited by this paper
• Protein hydration observed by X-ray diffraction. Solvation properties of penicillopepsin and neuraminidase crystal structures.

  1994cited by this paper
• PROCHECK: a program to check the stereochemical quality of protein structures

  1993cited by this paper
• Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase.

  1993cited by this paper
• Structural basis of amino acid alpha helix propensity.

  1993cited by this paper
• Structural basis of human erythrocyte glucose transporter function: pH effects on intrinsic fluorescence.

  1992cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

  1992cited by this paper
• Variability of conformations at crystal contacts in BPTI represent true low‐energy structures: Correspondence among lattice packing and molecular dynamics structures

  1992cited by this paper
• Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy.

  1992cited by this paper
• Heterologous expression and purification of active human phosphoribosylglycinamide formyltransferase as a single domain

  1992cited by this paper
• Histidine-aromatic interactions in barnase. Elevation of histidine pKa and contribution to protein stability.

  1992cited by this paper
• X-PLOR Version 3.1: A System for X-ray Crystallography and NMR

  1992cited by this paper
• Free R value: a novel statistical quantity for assessing the accuracy of crystal structures

  1992cited by this paper
• Neutral imidazole is the electrophile in the reaction catalyzed by triosephosphate isomerase: structural origins and catalytic implications.

  1991cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Sparse matrix sampling: a screening method for crystallization of proteins

  1991cited by this paper
• Active-site mapping and site-specific mutagenesis of glycinamide ribonucleotide transformylase from Escherichia coli.

  1990cited by this paper
• Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate.

  1990cited by this paper
• Subcloning, characterization, and affinity labeling of Escherichia coli glycinamide ribonucleotide transformylase.

  1990cited by this paper
• Mounting of crystals for macromolecular crystallography in a free-standing thin film

  1990cited by this paper
• Cryocrystallography of biological macromolecules: a generally applicable method.

  1988cited by this paper
• Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin.

  1985cited by this paper
• Analytical molecular surface calculation

  1983cited by this paper
• An analysis of the three-dimensional structure of chicken triose phosphate isomerase.

  1977cited by this paper
• Protein crystallography at sub-zero temperatures: cryo-protective mother liquors for protein crystals.

  1975cited by this paper

• Loop engineering in enzymes from structure to function: Mechanisms, methodologies, and engineering strategies.

  2025cites this paper
• pH Effects and Cooperativity among Key Titratable Residues for Escherichia coli Glycinamide Ribonucleotide Transformylase.

  2021cites this paper
• From Bioorganic Models to Cells.

  2021cites this paper
• PvdF of pyoverdin biosynthesis is a structurally unique N10-formyltetrahydrofolate-dependent formyltransferase.

  2019cites this paper
• Aptamer-Based Affinity Chromatography for Protein Extraction and Purification.

  2019cites this paper
• A Broad View Of Active Residues That Mediate Catalysis For Ornithine Transcarbamoylase And Glycinamide Ribonucleotide Transformylase

  2018cites this paper
• Synthesis of Novel 6-Substituted and 5-Substituted Pyrrolo[2,3-D] Pyrimidine Antifolates as Targeted Anticancer Therapies

  2018cites this paper
• Synthesis of 2,4,6-Substituted Pyrrolo[2,3-d]pyrimidines as Potential Anticancer Agents

  2017cites this paper
• Characterization of AICAR transformylase/IMP cyclohydrolase (ATIC) from Staphylococcus lugdunensis

  2017cites this paper
• pH-induced conformational changes in human ABO(H) blood group glycosyltransferases confirm the importance of electrostatic interactions in the formation of the semi-closed state.

  2014cites this paper
• Low-Abundance Protein Access by Combinatorial Peptide Libraries

  2013cites this paper
• Structural characterization of the siderophore rhodochelin from Rhodococcus jostii RHA1 and elucidation of its biosynthetic machinery

  2012cites this paper
• Protein preparation, crystallization and preliminary crystallographic studies of Bacillus subtilis glycinamide ribonucleotide transformylase.

  2009cites this paper
• Structures of glycinamide ribonucleotide transformylase (PurN) from Mycobacterium tuberculosis reveal a novel dimer with relevance to drug discovery.

  2009cites this paper
• Human glycinamide ribonucleotide transformylase: active site mutants as mechanistic probes.

  2007cites this paper
• Intracellular pH sensors: design principles and functional significance.

  2007cites this paper
• Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin.

  2006cites this paper
• Facilitation of protein 3-D structure determination using enhanced peptide amide deuterium exchange mass spectrometry (DXMS)

  2006cites this paper
• Simulation of pH‐dependent edge strand rearrangement in human β‐2 microglobulin

  2006cites this paper
• Crystal structure and mechanism of the Escherichia coli ArnA (PmrI) transformylase domain. An enzyme for lipid A modification with 4-amino-4-deoxy-L-arabinose and polymyxin resistance.

  2005cites this paper
• A quantum chemical study on the mechanism of glycinamide ribonucleotide transformylase inhibitor: 10-Formyl-5,8,10-trideazafolic acid.

  2005cites this paper
• The apo and ternary complex structures of a chemotherapeutic target: human glycinamide ribonucleotide transformylase.

  2005cites this paper
• The Crystal Structure of the Hydrolase Domain of 10-Formyltetrahydrofolate Dehydrogenase

  2004cites this paper
• Crystal Structures of Human Bifunctional Enzyme Aminoimidazole-4-carboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase in Complex with Potent Sulfonyl-containing Antifolates*

  2004cites this paper
• A quantum chemical study of the water-assisted mechanism in one-carbon unit transfer reaction catalyzed by glycinamide ribonucleotide transformylase.

  2004cites this paper
• Crystal Structure of Avian Aminoimidazole-4-carboxamide Ribonucleotide Transformylase in Complex with a Novel Non-folate Inhibitor Identified by Virtual Ligand Screening*

  2004cites this paper
• Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.

  2003cites this paper
• Application and limitations of X-ray crystallographic data in structure-based ligand and drug design.

  2003cites this paper
• The pH dependence of stability of the activation helix and the catalytic site of GART.

  2003cites this paper
• Structure of avian AICAR transformylase with a multisubstrate adduct inhibitor beta-DADF identifies the folate binding site.

  2003cites this paper
• Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.

  2002cites this paper
• Comparative study of folate cofactor models

  2002cites this paper
• A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.

  2002cites this paper
• Structural insights into the avian AICAR transformylase mechanism.

  2002cites this paper
• Native‐state conformational dynamics of GART: A regulatory pH‐dependent coil–helix transition examined by electrostatic calculations

  2001cites this paper
• Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.

  2001cites this paper
• Proton transfer dynamics of GART: The pH‐dependent catalytic mechanism examined by electrostatic calculations

  2001cites this paper
• On the Role of Conserved Histidine 106 in 10-Formyltetrahydrofolate Dehydrogenase Catalysis

  2001cites this paper
• The Unexpected Catalytic Properties of a Heterodimer of GAR Transformylase.

  2000cites this paper
• Crystallization and preliminary crystallographic investigations of avian 5-aminoimidazole-4-carboxamide ribonucleotide transformylase-inosine monophosphate cyclohydrolase expressed in Escherichia coli.

  2000cites this paper
• Catalytic mechanism of Escherichia coli glycinamide ribonucleotide transformylase probed by site-directed mutagenesis and pH-dependent studies.

  1999cites this paper
• New insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.

  1999cites this paper
• Aspartate 142 Is Involved in Both Hydrolase and Dehydrogenase Catalytic Centers of 10-Formyltetrahydrofolate Dehydrogenase*

  1999cites this paper